Remove topic cancer-treatments
article thumbnail

Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing

Benzinga

The asset platform includes two formulations: VAR-101 (topical) and VAR-102 (oral). Protein kinase inhibitors are a class of anti-cancer therapeutics that have made a significant impact on the treatment of cancers.

Finance 45
article thumbnail

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., announces continuous sales growth in ZTlido® with preliminary gross sales of approximately $8.1 million during the month of March 2022 and $18.4 million for 1Q2022

Benzinga

Strong year-over-year sales growth continues to be driven by the expanding payor coverage for ZTlido as a cornerstone of topical lidocaine treatment in neuropathic pain related to post-herpetic neuralgia (PHN) where it continues to be used as first-line therapy," said Jaisim Shah, Chief Executive Officer of Scilex.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cooley’s 2023 Life Sciences M&A Year in Review: Potent Mix of Creativity and Resilience Spurs Activity Heading Into 2024

Cooley M&A

Pfizer, which received a second request from the FTC in July, announced in December that it would donate the rights of royalties from sales of a cancer drug, licensed to Merck KGaA, to the American Association for Cancer Research to address concerns of the regulators, months after turning over commercialization of the drug to the German company.

article thumbnail

A Top DOJ Official Speaks on Corporate Enforcement and Compliance

Reynolds Holding

Which brings me to my next topic: the Fraud Section’s enforcement results over the past year. We believe in equality of all citizens, all people, all defendants under the law – and from Washington, D.C. to California, no one is above the law.

article thumbnail

Gibson Dunn Offers 2022 Mid-Year Securities Litigation Update

Reynolds Holding

Aspects of the decision in Goldstein suggest this is a topic that the court may be interested in exploring more in the future. As we discussed in our 2021 Year-End Securities Litigation Update , many cases remain focused on misstatements concerning the efficacy of COVID-19 diagnostic tests, vaccinations, and treatments. at *2, *47.